tiprankstipranks
Advertisement
Advertisement

GB:0R34 Stock Latest News

Apollo Global in talks to buy J&J’s orthopedics unit, Bloomberg reports
The FlyApollo Global in talks to buy J&J’s orthopedics unit, Bloomberg reports
2d ago
APO
JNJ
Apollo Global in discussions to buy JNJ’s orthopedics unit, Bloomberg reports
PremiumThe Fly
Apollo Global in discussions to buy JNJ’s orthopedics unit, Bloomberg reports
2d ago
APO
JNJ
Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX
PremiumThe Fly
Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX
3d ago
JNJ
Johnson & Johnson price target raised to $320 from $290 at HSBC
PremiumThe Fly
Johnson & Johnson price target raised to $320 from $290 at HSBC
3d ago
JNJ
Protagonist Therapeutics announces $300M share repurchase program
PremiumThe Fly
Protagonist Therapeutics announces $300M share repurchase program
5d ago
JNJ
TAK
Johnson & Johnson assumed with a Buy at UBS
PremiumThe FlyJohnson & Johnson assumed with a Buy at UBS
11d ago
JNJ
Stellantis appoints Stephanie Hartgrove chief communications officer
Premium
The Fly
Stellantis appoints Stephanie Hartgrove chief communications officer
13d ago
JNJ
STLA
FDA approves Imaavy for warm autoimmune hemolytic anemia
Premium
The Fly
FDA approves Imaavy for warm autoimmune hemolytic anemia
19d ago
JNJ
FDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
PremiumThe Fly
FDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
20d ago
JNJ
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
PremiumThe Fly
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
27d ago
JNJ
PTGX
Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition
PremiumThe Fly
Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition
27d ago
JNJ
ISRG
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
PremiumThe Fly
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
27d ago
JNJ
LEGN
Trump Trade: President signs EO to split up of childhood vaccines
PremiumThe FlyTrump Trade: President signs EO to split up of childhood vaccines
1M ago
AZN
EBS
Trump signs EO to split up of childhood vaccines, Bloomberg reports
Premium
The Fly
Trump signs EO to split up of childhood vaccines, Bloomberg reports
1M ago
AZN
EBS
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
Premium
The Fly
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
1M ago
JNJ
PTGX
Trump Trade: U.S. issues 15% duty on products made from polysilicon
PremiumThe Fly
Trump Trade: U.S. issues 15% duty on products made from polysilicon
1M ago
AZN
EBS
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
PremiumThe Fly
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
1M ago
AZN
EBS
Johnson & Johnson price target raised to $287 from $270 at Guggenheim
PremiumThe Fly
Johnson & Johnson price target raised to $287 from $270 at Guggenheim
1M ago
JNJ
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
1M ago
JNJ
JAZZ
JNJ’s OTTAVA Robotics and Medtech Strategy Underpin Buy Rating and Unchanged $282 Price Target
PremiumRatingsJNJ’s OTTAVA Robotics and Medtech Strategy Underpin Buy Rating and Unchanged $282 Price Target
1M ago
JNJ
Ottava Robotic Platform and MedTech Upside Underscore Buy Rating on JNJ with Unchanged $294 Price Target
Premium
Ratings
Ottava Robotic Platform and MedTech Upside Underscore Buy Rating on JNJ with Unchanged $294 Price Target
1M ago
JNJ
Johnson & Johnson announces leadership change in Innovative Medicine
Premium
Company Announcements
Johnson & Johnson announces leadership change in Innovative Medicine
1M ago
8K
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >